Concerns arise over primary care shortages; women struggle with coverage for effective nonhormonal treatments; FLiRT variants drive concerns amidst waning surveillance and immunity
NPs, PAs Join Specialties as Concerns Rise Over Primary Care Shortages
Increasingly, nurse practitioners (NPs) and physician assistants (PAs) are moving into specialty areas like cardiology and dermatology, broadening their skills and incomes, according to Kaiser Health News. This trend has worried experts who fear primary care might suffer from a shortage of these professionals. Despite the growing presence of NPs in specialty fields, projections suggest there will still be enough clinicians to meet primary care demands, but the distribution might challenge traditional health care models.
New Menopause Medications Face Insurance Hurdles Despite Promising Results
Innovative nonhormonal drugs like Bayer's elinzanetant and Astellas' fezolinetant (Veozah) have shown promise in reducing menopause symptoms, particularly hot flashes, according to NBC News. However, insurance companies often require women to try less effective medications first, making access difficult. Experts and patients have expressed frustration over these insurance barriers, emphasizing the need for better support for menopausal care.
New COVID-19 Variants Pose Summer Surge Risk
COVID-19 levels in the US are at historic lows, but the emergence of new FLiRT variants, particularly KP.2, has raised the possibility of a summer surge, according to CNN. These variants, which are more transmissible and immune-evasive, have overtaken previous strains, complicating predictions. Although the risk remains uncertain, experts urge caution, particularly looking ahead to the fall, when conditions could favor a larger resurgence.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More